*
YesNo
1. Discuss the ATS/ERS/JRS/ALAT treatment guidelines for patient screening and management.
2. Analyze clinical trial data of emerging therapeutics for IPF, and evaluate the safety and efficacy profiles of mono- and combination-therapy regimens.
3. Integrate disease monitoring tactics and appropriate therapy selection strategies into personalized treatment plans to improve outcomes and overall quality of life in patients with IPF.
*
*
On a scale of 1 to 5, with 1 meaning NOT at all confident and 5 meaning EXTREMELY confident.
12345
After participating in this activity, how confident are you in your ability to distinguish IPF/UIP from the other interstitial pneumonia subtypes?
After participating in this activity, how confident are you in your ability to develop individualized treatment plans to improve outcomes in patients with IPF?
*
*
*
*
1=Never 2=Not often 3=Sometimes 4=Often 5=Always 6=N/A
123456
1. Utilize appropriate measures and guidelines to accurately diagnose idiopathic pulmonary fibrosis
2. Apply knowledge from recent clinical trial data to develop personalized treatment plans
3. Understand early transplantation may improve outcomes, and survival in patients with idiopathic pulmonary fibrosis
4. Educate patients on pharmacologic and non-pharmacologic disease management to improve patient adherence and overall quality of life
*
1=Never 2=Not often 3=Sometimes 4=Often 5=Always 6=N/A for me
123456
1. Utilize appropriate measures and guidelines to accurately diagnose idiopathic pulmonary fibrosis
2. Apply knowledge from recent clinical trial data to develop personalized treatment plans
3. Understand early transplantation may improve outcomes, and survival in patients with idiopathic pulmonary fibrosis
4. Educate patients on pharmacologic and non-pharmacologic disease management to improve patient adherence and overall quality of life